The main purpose of this discovery, considered
A major leap forward in science was recently made in the United States, where a group of neuroscientists managed to adapt mice so that they could host functional human cells in their own brains. This innovation opens up a promising avenue for testing potential therapies for psychiatric and neurodevelopmental conditions that occur exclusively in humans, now using laboratory rodents as study models. Although the idea of partially human-brained mice might initially sound like a Kafkaesque experiment, the researchers emphasize that animals do not become „mice that think like humans”. In fact, these organisms have been genetically engineered and surgically surgically treated so that part of their brain tissue is of human origin. The papers, published in the journal Nature, have been subjected to rigorous independent ethical review.
The main purpose of this discovery, considered ethically complex, is to better understand the biology of brain disorders for which there are currently no effective treatments. Some of these conditions cannot be studied in simple mice because rodents do not develop certain human-specific brain disorders. Professor Sergiu Pasca of Stanford University, who led the research team, explained at a press conference that psychiatry faces one of the lowest success rates in clinical trials. He noted that even medicines that reach the clinical trial stage and appear to work excellently in animal models often fail dramatically in human medical practice. This, he added, indicates that a significant amount of information about human biology is missing, and capturing it will be essential for progress. Stanford researchers say that for certain complex conditions, including epilepsy, autism, and cerebral palsy, the new methodology has transformative potential.
Pasca pointed out that we now have a new model that allows us to capture aspects of human brain function in a way that has never been possible before.
The human brain is made up of billions of cells, interconnected in millions of circuits, making it difficult to understand its development and the exact mechanisms that occur at the cellular level when dysfunctions occur. Although this is not the first time that human neurons have been implanted in rodents in a laboratory, these researchers have taken this approach to a new level. First, they genetically modified the mice to develop almost none of their own cerebral cortex, the outer layer of the brain sometimes known as gray matter, which manages higher-level thinking, memory, and senses. Subsequently, the researchers used skin cells taken from humans and reprogrammedthem to grow into fragments of brain-like tissue. These structures, called organoids, are not whole brains grown in vessels, but rather collections of interconnected living cells.
When these organoids were implanted into the brains of mice
When these organoids were implanted into the brains of mice, the cells divided and organized into the animal's existing brain circuitry, establishing connections with the rest of the brain and the mouse's spinal cord. The cortex of the implanted mice is not perfect; a normal cortex forms organized and structured layers. In scans of implanted mice, the researchers were able to clearly observe the connections between human brain cells and the rest of the mouse's brain. This hybrid network provides a unique window into neural interactions. The study also raised important questions about what it means to change the way laboratory animals think and feel. The Stanford team hopes that this breakthrough will provide a new method of investigating the biology of human brain disorders, helping to bridge the gap between laboratory outcomes and clinical success.
The process required sophisticated genetic engineering, ensuring that mice had space to integrate human tissue without completely losing their own vital brain functions.
The impact of this technology extends beyond academic curiosity. By partially removing the mouse's native cortex, the researchers created a receptive environment for reprogrammed human cells. They demonstrated the ability to functionally integrate into the host's neural networks. Although the resulting cortex exhibits certain structural imperfections compared to the standard human, the existence of electrical and chemical connections between the two cell types is key evidence of the viability of the model. Professor Pasca insisted that this model allows capturing aspects of human brain function that were previously inaccessible, providing a robust platform for drug testing. High failure rate of clinical trials in psychiatrists